The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer's Disease

被引:18
|
作者
Sun, Jia-Hao [1 ]
Wang, Hui-Fu [2 ]
Zhu, Xi-Chen [2 ]
Yu, Wan-Jiang [3 ]
Tan, Chen-Chen [1 ]
Jiang, Teng [4 ]
Tan, Meng-Shan [1 ]
Tan, Lan [1 ,2 ]
Yu, Jin-Tai [1 ,2 ,5 ]
机构
[1] Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Neurol, 5 Donghai Middle Rd, Qingdao 266071, Shandong, Peoples R China
[2] Nanjing Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China
[3] Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Radiol, Qingdao, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[5] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, 675 Nelson Rising Lane,Suite 190,Box 1207, San Francisco, CA 94158 USA
基金
美国国家卫生研究院; 加拿大健康研究院; 中国国家自然科学基金;
关键词
UNC5C; Alzheimer's disease; Neuroimaging; Biomarker; ADNI; MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; INITIATIVE ADNI; ATROPHY; MRI; VARIANTS; MEMORY; BIOMARKERS; DEMENTIA; NETRIN-1;
D O I
10.1007/s12035-015-9589-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
UNC5C, which is a transmembrane receptor for netrin-1 to trigger the apoptosis, has been confirmed as a new risk factor for Alzheimer's disease (AD) recently. However, there is lack of the evidence on the brain structure associated with the polymorphisms of UNC5C in AD. The objective of this study is to investigate the influence of UNC5C loci on the neuroimaging of strategic regions of AD. In 812 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, we explored the genotypes of UNC5C loci in the volumes of the hippocampus, parahippocampal gyrus, posterior cingulate gyrus, middle temporal and precuneus, and the thickness of the entorhinal cortex which are measured by magnetic resonance imaging (MRI). We also investigated the atrophy rate of above structures influenced by UNC5C loci using the longitudinal data. UNC5C loci were associated with the volume of right middle temporal (rs34585936 P-c = 0.0031). Meanwhile, the polymorphisms of UNC5C loci could alter the atrophy rate of strategic regions especially the left hippocampus (rs72672784 P-c = 0.0090; rs13120458 P-c = 0.0434; rs34875919 P-c = 0.0434) and right precuneus (rs72672784 P-c = 0.0068; rs2001246 P-c = 0.0055; rs74690179 P-c = 0.0055). UNC5C genotypes were significantly associated with the volume of the middle temporal on MRI; meanwhile, UNC5C loci could alter the atrophy of strategic regions of AD such as the hippocampus and precuneus. And the above effects of polymorphisms of UNC5C were more obvious in the population with the impaired cognition than those with the normal cognition.
引用
收藏
页码:6759 / 6767
页数:9
相关论文
共 50 条
  • [21] Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
    Barnes, Josephine
    Carmichael, Owen T.
    Leung, Kelvin K.
    Schwarz, Christopher
    Ridgway, Gerard R.
    Bartlett, Jonathan W.
    Malone, Ian B.
    Schott, Jonathan M.
    Rossor, Martin N.
    Biessels, Geert Jan
    DeCarli, Charlie
    Fox, Nick C.
    NEUROBIOLOGY OF AGING, 2013, 34 (08) : 1996 - 2002
  • [22] Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma
    Lv, Dan
    Zhao, Wei
    Dong, Dong
    Qian, Xiao-Ping
    Zhang, Yu
    Tian, Xiao-Jun
    Zhang, Jun
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (13) : 2068 - 2076
  • [23] Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative
    Meda, Shashwath A.
    Koran, Mary Ellen I.
    Pryweller, Jennifer R.
    Vega, Jennifer N.
    Thornton-Wells, Tricia A.
    NEUROBIOLOGY OF AGING, 2013, 34 (05) : 1518.e9 - 1518.e18
  • [24] The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update
    Hendrix, James A.
    Finger, Brad
    Weiner, Michael W.
    Frisoni, Giovanni B.
    Iwatsubo, Takeshi
    Rowe, Christopher C.
    Kim, Seong Yoon
    Guinjoan, Salvador M.
    Sevlever, Gustavo
    Carrillo, Maria C.
    ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 850 - 859
  • [25] Neuroimaging for Early Diagnosis of Alzheimer's Disease: a Review
    Ou, Chang-Hsien
    Liu, Tse-Jung
    Cheng, Chiu-Shih
    Lin, Pei-Ling
    Lee, Cheng-Lung
    CLINICAL LABORATORY, 2024, 70 (06) : 1055 - 1068
  • [26] The role of neuroimaging in Alzheimer's disease
    Colliot, O.
    Chupin, M.
    Sarazin, M.
    Habert, M. -O.
    Dormont, D.
    Lehericy, S.
    PSN-PSYCHIATRIE SCIENCES HUMAINES NEUROSCIENCES, 2008, 6 (02): : 68 - 75
  • [27] Molecular Neuroimaging in Alzheimer's Disease
    Matsuda, Hiroshi
    Imabayashi, Etsuko
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2012, 22 (01) : 57 - +
  • [28] Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review
    Alves, Gilberto Sousa
    Carvalho, Andre Ferrer
    de Carvalho, Luiza de Amorim
    Sudo, Felipe Kenji
    Siqueira-Neto, Jose Ibiapina
    Oertel-Knoechel, Viola
    Jurcoane, Alina
    Knoechel, Christian
    Boecker, Henning
    Laks, Jerson
    Pantel, Johannes
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (01) : 61 - 75
  • [29] Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative
    Jack, Clifford R., Jr.
    Bernstein, Matt A.
    Borowski, Bret J.
    Gunter, Jeffrey L.
    Fox, Nick C.
    Thompson, Paul M.
    Schuff, Norbert
    Krueger, Gunnar
    Killiany, Ronald J.
    DeCarli, Charles S.
    Dale, Anders M.
    Carmichael, Owen W.
    Tosun, Duygu
    Weiner, Michael W.
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 212 - 220
  • [30] The Alzheimer's Disease Neuroimaging Initiative: Perspectives of the Industry Scientific Advisory Board
    Schmidt, Mark E.
    Siemers, Eric
    Snyder, Peter J.
    Potter, William Z.
    Cole, Patricia
    Soares, Holly
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 286 - 290